quinidine has been researched along with phenobarbital in 53 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 30 (56.60) | 18.7374 |
1990's | 3 (5.66) | 18.2507 |
2000's | 12 (22.64) | 29.6817 |
2010's | 8 (15.09) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
Topliss, JG; Yoshida, F | 1 |
Abraham, MH; Acree, WE; Ibrahim, A | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Bianucci, AM; Calderone, V; Coi, A; Massarelli, I; Testai, L | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Venho, VM | 3 |
Briggs, WA; Gibson, TP; Matusik, E; Nelson, LD | 1 |
Data, JL; Nies, AS; Wilkinson, GR | 1 |
Advenier, C; Leroyer, R; Pays, M; Varoquaux, O | 1 |
Gal, J; Molitoris, BA; Nakata, LM; Sedman, AJ | 1 |
Benhamou, JP; Bernuau, J; Bourlière, M; Rueff, B | 1 |
Caron, G; Sheehan, M | 1 |
Pitterle, ME; Sorkness, CA; Wiederholt, JB | 1 |
Mico, B; Rakhit, A | 1 |
Kellaway, GS; McCrae, E | 1 |
Homola, D; Rotrekl, J; Srnová, V | 1 |
Huttman, DH | 1 |
Mah, GK | 1 |
Bailey, KR; Gallo, DG; Sheffner, AL | 1 |
French, WN; Morrison, JC | 1 |
Grosser, KD; Humpert, U | 1 |
Spesshardt, K; Wimmer, H | 1 |
Klotz, U | 1 |
Effeney, DJ; Holford, NH; Rakhit, A; Riegelman, S | 1 |
Risler, T; Seipel, L | 1 |
Blackman, MS; Rodgers, GC | 1 |
Clotet, B; Moragas, A; Rubiés-Prat, J; Vidal, MT | 1 |
Bonora, MR; Guaglio, R; Rondanelli, R; Terzoni, PA | 1 |
Bachmann, KA; Jauregui, L | 1 |
Kagayama, A; Mitani, Y; Niwa, T; Shiraga, T; Terakawa, M; Tokuma, Y | 1 |
Ma, Y; Tang, X; Yang, X | 1 |
Wu, SG; Zhu, ZG | 1 |
SCHMIDT-VOIGT, J | 1 |
KIMURA, E | 1 |
MACKENZIE, GJ; PASCUAL, S | 1 |
FOERSTER, K; KROETZ, C | 1 |
BECK, IT; FROMMEL, E | 1 |
de Lange, EC; Eriksson, J; Koepp, M; Labots, M; Lammertsma, AA; Potschka, H; Rongen, M; Russmann, V; Schuit, R; Seeger, N; Syvänen, S; van Kooij, R; Verbeek, J; Voskuyl, RA; Windhorst, AD; Zellinger, C | 1 |
1 review(s) available for quinidine and phenobarbital
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for quinidine and phenobarbital
Article | Year |
---|---|
[Use of Coritrate in the prevention of paroxysmal tachycardia].
Topics: Adult; Aged; Ajmaline; Cardiac Glycosides; Clinical Trials as Topic; Drug Combinations; Female; Humans; Male; Meprobamate; Middle Aged; Phenobarbital; Procainamide; Quinidine; Tachycardia, Paroxysmal; Theophylline | 1973 |
Use of single sample clearance estimates of cytochrome P450 substrates to characterize human hepatic CYP status in vivo.
Topics: Administration, Oral; Adult; Antipyrine; Aryl Hydrocarbon Hydroxylases; Carbamazepine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Ethosuximide; Humans; Liver; Lorazepam; Male; Oxidoreductases, N-Demethylating; Phenobarbital; Phenytoin; Quinidine; Rifampin; Smoking; Theophylline; Valproic Acid | 1993 |
50 other study(ies) available for quinidine and phenobarbital
Article | Year |
---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Identification of "toxicophoric" features for predicting drug-induced QT interval prolongation.
Topics: Amino Acid Sequence; Heart; Humans; Models, Molecular; Molecular Sequence Data; Molecular Structure; Protein Subunits; Sequence Alignment; Structure-Activity Relationship; Trans-Activators; Transcriptional Regulator ERG | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Effect of methotrexate on drug absorption from the rat small intestine in situ and in vitro.
Topics: Animals; Female; In Vitro Techniques; Intestinal Absorption; Intestine, Small; Isoniazid; Mecamylamine; Methotrexate; Phenobarbital; Quinidine; Rats; Sulfisoxazole; Time Factors | 1976 |
Drug absorption from the small intestine of the triparanol-treated rat in situ.
Topics: Animals; Female; Injections, Intravenous; Intestinal Absorption; Intestine, Small; Isoniazid; Mecamylamine; Phenobarbital; Quinidine; Rats; Sulfisoxazole; Triparanol | 1976 |
Artificial kidneys and clearance calculations.
Topics: Blood Flow Velocity; Humans; Kidneys, Artificial; Mathematics; Metabolic Clearance Rate; Pharmaceutical Preparations; Phenobarbital; Plasma; Procainamide; Quinidine; Renal Dialysis; Urea | 1976 |
Drug absorption from the irradiated rat small intestine in situ.
Topics: Animals; Female; Gamma Rays; Intestinal Absorption; Intestine, Small; Isoniazid; Kinetics; Mecamylamine; Phenobarbital; Quinidine; Rats; Sulfisoxazole; Time Factors | 1976 |
Interaction of quinidine with anticonvulsant drugs.
Topics: Adult; Arrhythmias, Cardiac; Depression, Chemical; Drug Interactions; Enzyme Induction; Epilepsy; Female; Half-Life; Humans; Kinetics; Male; Phenobarbital; Phenytoin; Prothrombin Time; Quinidine | 1976 |
Quinidine oxidative metabolism. Identification and biosynthesis of quinidine 10,11-dihydrodiol stereoisomers.
Topics: Animals; Bile; Chromatography, High Pressure Liquid; Cyclic N-Oxides; Gas Chromatography-Mass Spectrometry; Humans; Liver; Male; Molecular Structure; Phenobarbital; Quinidine; Quinine; Rats; Rats, Inbred Strains; Stereoisomerism | 1990 |
Therapeutic drug monitoring in patients with chronic renal failure: evaluation of the Abbott TDx drug assay system.
Topics: Carbamazepine; Cross Reactions; Digoxin; Gentamicins; Humans; Immunoassay; Kidney Failure, Chronic; Lidocaine; Monitoring, Physiologic; Pharmaceutical Preparations; Phenobarbital; Phenytoin; Quinidine; Valproic Acid; Vancomycin | 1986 |
Quinidine phenylethylbarbiturate-induced fulminant hepatitis in a pregnant woman. A case report.
Topics: Adult; Chemical and Drug Induced Liver Injury; Drug Combinations; Female; Humans; Phenobarbital; Pregnancy; Pregnancy Complications; Quinidine | 1988 |
Evaluation of an automated system (Optimate) for substrate-labeled fluorescent immunoassays.
Topics: Anti-Bacterial Agents; Carbamazepine; Evaluation Studies as Topic; Fluorescent Antibody Technique; Humans; Immunoenzyme Techniques; Indicators and Reagents; Methods; Phenobarbital; Phenytoin; Primidone; Quinidine; Theophylline | 1985 |
Use of serum drug concentrations in outpatient clinics.
Topics: Carbamazepine; Digoxin; Humans; Medication Systems, Hospital; Outpatient Clinics, Hospital; Pharmaceutical Preparations; Phenobarbital; Phenytoin; Procainamide; Quinidine; Theophylline; Wisconsin | 1985 |
Kinetics of microsomal metabolism of quinidine in rats.
Topics: Animals; Cytochrome P-450 Enzyme System; In Vitro Techniques; Kinetics; Male; Microsomes, Liver; Phenobarbital; Quinidine; Rats; Rats, Inbred Strains | 1985 |
Intensive monitoring for adverse drug effects in patients discharged from acute medical wards.
Topics: Adolescent; Adult; Age Factors; Aged; Drug Interactions; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Edema; Ethnicity; Female; Glyburide; Glycyrrhiza; Hematologic Diseases; Hospitalization; Humans; Male; Middle Aged; New Zealand; Outpatient Clinics, Hospital; Phenobarbital; Plants, Medicinal; Purpura, Thrombocytopenic; Quinidine; Sex Factors; Succinates; Triterpenes; Warfarin | 1973 |
[Aspirin in the treatment of myocardial infarct].
Topics: Aspirin; Bicarbonates; Blood Coagulation; Blood Sedimentation; Gastrointestinal Diseases; Hematuria; Heparin; Humans; Myocardial Infarction; Papaverine; Phenobarbital; Quinidine; Theophylline | 1971 |
Cardioversion in the treatment of atrial flutter.
Topics: Adult; Aged; Atrial Flutter; Digoxin; Electric Countershock; Female; Humans; Male; Middle Aged; Phenobarbital; Propranolol; Quinidine | 1969 |
The interaction between cholestyramine and drugs.
Topics: Adsorption; Animals; Aspirin; Bile Acids and Salts; Blood; Chlorothiazide; Cholestyramine Resin; Dogs; Intestinal Absorption; Nicotinic Acids; Phenobarbital; Phenylbutazone; Quinidine; Rats; Spectrophotometry; Tetracycline; Urine; Warfarin | 1965 |
Identification of complexes of phenobarbital with quinine, quinidine, or hydroquinidine in pharmaceutical dosage forms.
Topics: Chemistry, Pharmaceutical; Dosage Forms; Phenobarbital; Quinidine; Quinine; Spectrum Analysis | 1965 |
[On the therapy of the combination form of Adams-Stokes syndrome with orciprenaline].
Topics: Adams-Stokes Syndrome; Aged; Bronchodilator Agents; Electric Countershock; Female; Humans; Meperidine; Metaproterenol; Phenethylamines; Phenobarbital; Phytotherapy; Plants, Medicinal; Procainamide; Quinidine; Rauwolfia; Resorcinols; Ventricular Fibrillation | 1966 |
[The treatment of heart diseases from various causes with the combination preparation Spasmo-Guttacor].
Topics: Coronary Disease; Heart Failure; Humans; Papaverine; Phenobarbital; Plants, Medicinal; Quinidine | 1966 |
Performance of a new automated substrate-labeled fluorescence immunoassay system evaluated by comparative therapeutic monitoring of five drugs.
Topics: Autoanalysis; Carbamazepine; Chromatography, Gas; Chromatography, High Pressure Liquid; Drug Stability; Fluorescent Antibody Technique; Humans; Pharmaceutical Preparations; Phenobarbital; Phenytoin; Quinidine; Spectrometry, Fluorescence; Theophylline | 1984 |
Induction of quinidine metabolism and plasma protein binding by phenobarbital in dogs.
Topics: Animals; Blood Proteins; Dogs; Injections, Intravenous; Kinetics; Models, Biological; Phenobarbital; Portal Vein; Protein Binding; Quinidine | 1984 |
[Controlled digitalis therapy].
Topics: Cholestyramine Resin; Digitalis Glycosides; Digitoxin; Digoxin; Dose-Response Relationship, Drug; Drug Interactions; Heart Failure; Humans; Patient Compliance; Phenobarbital; Quinidine; Rifampin | 1983 |
Quinidine interaction with anticonvulsants.
Topics: Anticonvulsants; Child, Preschool; Drug Interactions; Half-Life; Humans; Male; Phenobarbital; Phenytoin; Quinidine | 1983 |
[Angioimmunoblastic lymphadenopathy. Immunocytochemical, morphological and mathematical study of lymph node biopsy (author's transl)].
Topics: Aged; Biopsy; Drug Combinations; Female; Histocytochemistry; Humans; Immunoblastic Lymphadenopathy; Liver; Lymph Nodes; Mathematics; Phenobarbital; Quinidine | 1981 |
Clinical pharmacokinetics: the pharmacological monitoring of plasmatic levels in therapy.
Topics: Digoxin; Drug Administration Schedule; Gentamicins; Humans; Kinetics; Pharmaceutical Preparations; Phenobarbital; Phenytoin; Quinidine; Salicylates; Theophylline | 1980 |
Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
Topics: Animals; Anti-Arrhythmia Agents; Aryl Hydrocarbon Hydroxylases; beta-Naphthoflavone; Cell Line; Chromatography, High Pressure Liquid; Clofibrate; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dexamethasone; Female; Humans; Imidazoles; Ketoconazole; Kinetics; Male; Microsomes; Microsomes, Liver; Oxidoreductases, N-Demethylating; Phenobarbital; Quinidine; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Sex Factors; Stereoisomerism | 2000 |
[The adsorption on attapulgite and cross-linked agar beads entrapped attapulgite(CAA)].
Topics: Adsorption; Agar; Chlorpromazine; Diazepam; Magnesium Compounds; Phenobarbital; Quinidine; Silicon Compounds | 2000 |
Fibrinogenolytic properties of natrahagin (a proteinase from cobra venom) and its effect on human platelet aggregation.
Topics: Adult; Dose-Response Relationship, Drug; Drug Combinations; Elapid Venoms; Fibrinogen; Fibrinolytic Agents; Humans; Male; Metalloendopeptidases; Phenobarbital; Platelet Aggregation; Platelet Aggregation Inhibitors; Quinidine | 1999 |
[Extrasystolic heart rhythm disorders; practical viewpoints on diagnosis and therapy].
Topics: Arrhythmias, Cardiac; Humans; Phenobarbital; Plant Extracts; Procainamide; Quinidine; Vestibule, Labyrinth | 1958 |
[ARRHYTHMIA].
Topics: Adrenal Cortex Hormones; Arrhythmias, Cardiac; Atropine; Diagnosis, Differential; Ephedrine; Epinephrine; Heart Block; Humans; Isoproterenol; Phenobarbital; Procainamide; Quinidine; Reserpine; Tachycardia | 1963 |
PAROXYSMAL VENTRICULAR TACHYCARDIA.
Topics: Coronary Disease; Diagnosis; Digitalis Glycosides; Electrocardiography; Heart Failure; Hydrocortisone; Morphine; Mortality; Myocardial Infarction; Phenobarbital; Procainamide; Quinidine; Rheumatic Heart Disease; Statistics as Topic; Tachycardia; Tachycardia, Paroxysmal; Tachycardia, Ventricular; Toxicology | 1964 |
[ANTI-ARRHYTHMIC SUBSTANCES IN THE TREATMENT OF THE HEART].
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cardiac Complexes, Premature; Drug Therapy; Heart; Humans; Meprobamate; Phenobarbital; Procainamide; Quinidine; Rauwolfia; Tachycardia; Tachycardia, Paroxysmal; Theophylline; Ventricular Fibrillation | 1965 |
[The combination of phenobarbital and quinidine in the treatment of cardiovascular, autonomic cardiac neuroses extrasystoles, paroxysmal tachycardia].
Topics: Arrhythmias, Cardiac; Autonomic Nervous System; Barbiturates; Cardiac Complexes, Premature; Cardiovascular System; Humans; Neurocirculatory Asthenia; Phenobarbital; Quinidine; Tachycardia, Paroxysmal | 1948 |
[11C]quinidine and [11C]laniquidar PET imaging in a chronic rodent epilepsy model: impact of epilepsy and drug-responsiveness.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzazepines; Carbon Radioisotopes; Chronic Disease; Disease Models, Animal; Epilepsy; Female; Gene Expression Regulation; Kinetics; Male; Phenobarbital; Positron-Emission Tomography; Quinidine; Quinolines; Radiochemistry; Rats; Rats, Sprague-Dawley; Recurrence; Treatment Outcome | 2013 |